Allergy Immunotherapy Industry Insights: Market Forecast to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Allergy Immunotherapy Market Expected To Become By 2029 Compared With Its 2025 Level?

The allergy immunotherapy market size has shown robust expansion in recent years. This market is set to increase from $2.88 billion in 2024 to $3.16 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.9%. The growth observed in the past can be linked to the rising prevalence of allergic diseases, advancements in immunotherapy techniques, increased patient awareness, government initiatives, and improvements in research and development.

The allergy immunotherapy market is poised for significant expansion in the coming years. Projections indicate it will reach $5.03 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.3%. This anticipated growth during the forecast period is fueled by factors such as the escalating global prevalence of allergies, supportive healthcare policies, greater adoption of immunotherapy treatments, the development of new markets and previously unexplored areas, and increased spending on healthcare. Key trends anticipated for this period encompass technological innovations in treatments, a growing incidence of allergies, enhanced patient understanding and education, the integration of telemedicine and remote monitoring solutions, and the development of personalized treatment regimens.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9416&type=smp

What Are The Drivers Pushing New Developments In The Allergy Immunotherapy Market?

The increasing occurrence of allergic conditions is anticipated to stimulate the expansion of the allergy immunotherapy market moving forward. Allergic disorders are characterized by excessive immune reactions to particular antigens. In contrast, immune responses mistakenly targeting intrinsic bodily components (self) lead to autoimmune diseases. Allergy immunotherapy is offered to atopic individuals experiencing allergy disorders, such as IgE-mediated allergic rhinitis and allergic asthma, triggered by inhaled allergens like pollens and house dust mites (HDMs). For example, in August 202, the Medicines and Healthcare Products Regulatory Agency (MHRA), a UK-based executive agency, reported that in 2022-23, English hospitals noted over 25,000 admissions for allergies and anaphylaxis, exceeding twice the figure observed in the past twenty years. Furthermore, in May 2024, the Food Standards Agency, a UK-based government department, released the Patterns and Prevalence of Adult Food Allergy (PAFA) report, indicating that about 6% of adults in the UK suffer from food allergies, totaling approximately 2.4 million individuals. Consequently, the growing prevalence of allergic disorders is fueling the expansion of the allergy immunotherapy market.

How Is The Allergy Immunotherapy Market Segmented?

The allergy immunotherapymarket covered in this report is segmented –

1) By Allergy Type: Allergic Rhinitis; Asthma; Food Allergy; Venom Allergy; Other Allergy Types

2) By Treatment: Subcutaneous Immunotherapy (SCIT); Sublingual Immunotherapy; Specific Immunotherapy (SIT)

3) By Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

Subsegments:

1) By Allergic Rhinitis: Seasonal Allergic Rhinitis; Perennial Allergic Rhinitis

2) By Asthma: Allergic Asthma; Non-Allergic Asthma

3) By Food Allergy: Peanut Allergy; Tree Nut Allergy; Milk Allergy; Egg Allergy; Other Food Allergies

4) By Venom Allergy: Insect Sting Allergy; Other Venom Allergies

5) By Other Allergy Types: Allergic Conjunctivitis; Eczema; Drug Allergies; Other Environmental Allergies

What Key Innovation Trends Are Fueling Advancements In The Allergy Immunotherapy Market?

Major companies within the allergy immunotherapy market are innovating with technological products, such as artificial intelligence (AI)-powered allergy component testing, to sustain their market position. This AI-powered allergy component testing constitutes a novel platform for diagnostics, leveraging component resolved diagnostics (CRD) to identify various forms of allergies. For instance, in May 2023, Metropolis Healthcare Limited, an Indian-based medical laboratory company, launched its artificial intelligence (AI)-powered allergy component testing. This technology is considered a fourth-generation allergy testing method that employs Artificial Intelligence (AI) to aid clinicians in making informed clinical decisions. It offers substantial insights, facilitating the selection and optimization of treatment courses for allergic diseases. Additionally, it possesses the capability to predict the effectiveness of immunotherapy for allergy vaccinations.

Which Leading Companies Dominate The Allergy Immunotherapy Market Share?

Major companies operating in the allergy immunotherapy market include LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics plc, ALK-Abelló A/S, HAL Allergy B.V., DBV Technologies, Circassia Pharmaceuticals Inc., Jubilant HollisterStier LLC, Allergopharma GmbH & Co. KG, Biomay AG, Anergis SA, HollisterStier Allergy, Mylan N.V., Adamis Pharmaceuticals Corporation, Desentum Oy, WOLW Pharma Limited, AllerGenics Inc., Greer Laboratories Inc., Aimmune Therapeutics Inc., Reliant Laboratories Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Danaher Corporation, QIAGEN NV, Merck & Co. Inc., Pfizer Inc., Novartis AG, GlaxoSmithKline plc, AstraZeneca plc, Sanofi SA, Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

Which Region Is Projected To Lead The Allergy Immunotherapy Market During The Forecast Period?

Europe was the largest region in the allergy immunotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the allergy immunotherapy market report during the forecast period. The regions covered in the allergy immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Allergy Immunotherapy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9416&type=smp

Browse Through More Reports Similar to the Global Allergy Immunotherapy Market 2025, By The Business Research Company

Wound Care Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wound-care-devices-global-market-report

Benign Prostatic Hyperplasia Bph Treatment Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

Pain Management Devices And Therapies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pain-management-devices-and-therapies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795